| Old Articles: <Older 1211-1220 Newer> |
|---|
 |
Managed Care
May 2004 |
Physician Pay Remains Flat, But Bonuses Rise The increased use of bonuses represents the physician market getting more competitive.   |
Managed Care
May 2004
Thomas Morrow |
New Agents Regulating Tyrosine Kinase Can Be Used Against Several Cancers When traditional therapies fail in cancer treatment, turning off a chemical switch may offer hope to the hopeless. |
BusinessWeek
June 7, 2004
Gene G. Marcial |
St. Jude's Bruise Should Clear Up Fast St. Jude Medical (STJ ) tumbled 2%, to $73, after it revealed that the FDA had delayed for a month the approval of its new Epic CRT-defibrillator. |
The Motley Fool
May 28, 2004
Roger Nusbaum |
Stryker Stands Out This is one medical equipment maker that looks good. |
The Motley Fool
May 28, 2004
Richard Gibbons |
Quality Systems a Picture of Health Earnings are great, but can the medical systems developer maintain its torrid growth rate? |
The Motley Fool
May 28, 2004
W.D. Crotty |
Boston Scientific's Stent Gold Mine The company is starting two or more years of high profitability. |
The Motley Fool
May 27, 2004
Jeff Hwang |
Guidant's Stent Stumble Yesterday, Guidant said that a regulatory filing for marketing approval of its Champion stainless steel stent could be delayed up to six months due to "issues" that may result in "manufacturing process modifications and/or stent design changes." |
The Motley Fool
May 26, 2004
Charly Travers |
Elan and Biogen File for Approval There's a new multiple sclerosis drug on the horizon. |
The Motley Fool
May 26, 2004
Alyce Lomax |
Medtronic Takes Heart After the stock drops on data, what does the company have to say? |
The Motley Fool
May 25, 2004
Brian Gorman |
Omnicare Keeps Buying Omnicare has decided it won't take no for an answer in its pursuit of another competitor as it continues an accelerating buying spree. |
| <Older 1211-1220 Newer> Return to current articles. |
